Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of &bgr;arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia

Inhibition of &bgr;arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia

US Patent 6528271 · Granted Mar 4, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

System and method for homogenous GPCR phosphorylation and identification of beta2024
Synthesis of 20-nor-salvinorin A2022
Complex BRET technique for measuring biological interactions2022
Compositions and methods of enhancing 5-hydroxytryptophan bioavailability2022
Antagonists of the kappa opioid receptor2020
Signaling-biased mu opioid receptor agonists2020
Methods of treating fragile X syndrome and related disorders2020
Antagonists of the kappa opioid receptor2018
Small molecule agonists of neurotensin receptor 12018
Method of treating cancer that overexpresses TopBP12017
Methods of treatment using arylcyclopropylamine compounds2017
Kappa opioid receptor effectors and uses thereof2017